Navigation Links
PTC Therapeutics Announces Initiation of Phase 2b Registration-Directed Clinical Trial of PTC124 in Duchenne/Becker Muscular Dystrophy
Date:4/23/2008

ng and life-threatening disorder."

Stuart W. Peltz, Ph.D., President and Chief Executive Officer of PTC Therapeutics added, "Initiation of the Phase 2b trial is an important milestone for PTC. The trial builds on the results we have achieved to date in DMD and cystic fibrosis (CF) and constitutes a major step forward in establishing the potential for PTC124 as a paradigm shift in the treatment of genetic disorders. Our future plans for PTC124 include the initiation of longer-term studies in CF, as well as additional proof-of-concept studies in other indications."

About Duchenne and Becker Muscular Dystrophy

Duchenne and Becker muscular dystrophy (DMD/BMD) are progressive muscle disorders that cause the loss of both muscle function and independence. DMD/BMD is perhaps the most prevalent of the muscular dystrophies and is the most common lethal genetic disorder diagnosed during childhood today. Each year, approximately 20,000 children worldwide are born with DMD (one of every 3,500 male children). It is estimated that one in 10 DMD patients are likely to have a Becker presentation, a milder form of the disease that is associated with later manifestation of symptoms. In essence, DMD and BMD represent a continuum of the same disease. More information regarding DMD and BMD is available through the Muscular Dystrophy Association (http://www.mdausa.org), the Parent Project Muscular Dystrophy (http://www.parentprojectmd.org), and the Association Francaise contre les Myopathies (http://www.afm-france.org).

About PTC124

PTC124 is an orally delivered investigational new drug in Phase 2 clinical development for the treatment of genetic disorders due to nonsense mutations. Nonsense mutations are single-point alterations in the genetic code that prematurely halt the translation process
'/>"/>

SOURCE PTC Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Halozyme Therapeutics Presents Findings on Combinations of rHuPH20 Enzyme With Bisphosphonates at the American Association for Cancer Research Conference
2. Halozyme Therapeutics Presents Pre-Clinical Studies of Systemic Delivery of Pegylated rHuPH20 Enyzme in Prostate Cancer Models at American Association for Cancer Research Conference
3. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
4. Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System
5. Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach
6. European Regulatory Agency Accepts Cell Therapeutics, Inc.s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
7. CV Therapeutics Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN-TIMI 36 Patients With Angina
8. Michael J. Fox Foundation Commits up to $10 Million for Pre-Clinical Drug Development Under Therapeutics Development Initiative
9. Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions
10. Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL
11. Dynamis Therapeutics, Inc. Discovers RAGE Inhibitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... , Aug. 20, 2014 Reportlinker.com announces ... in its catalogue: Global Coatings for ... This report analyzes the ... US$ Million by the following Product Segments: Active ... The report provides separate comprehensive analytics for the ...
(Date:8/20/2014)... Mich. and PHOENIX ... corporation established to bring cutting-edge next-generation sequencing and ... cancer patients, today announced a collaboration with TESARO, ... to characterize patient tissue samples from clinical trials ... or resistant to TESARO,s TSR-011.  This may lead to ...
(Date:8/20/2014)... CITY , Aug. 20, 2014 ApolloDx™ ... mobile diagnostic platform during a special event at the ... , on September 5, 2014. The event, which ... on the ApolloDx website, www.apollodx.com .    ... diagnostic testing," said Jared Bauer , Co-Founder and ...
Breaking Medicine Technology:Global Coatings for Medical Devices Industry 2Global Coatings for Medical Devices Industry 3Global Coatings for Medical Devices Industry 4Global Coatings for Medical Devices Industry 5Global Coatings for Medical Devices Industry 6Global Coatings for Medical Devices Industry 7Global Coatings for Medical Devices Industry 8Global Coatings for Medical Devices Industry 9Global Coatings for Medical Devices Industry 10Global Coatings for Medical Devices Industry 11Global Coatings for Medical Devices Industry 12Global Coatings for Medical Devices Industry 13Global Coatings for Medical Devices Industry 14Global Coatings for Medical Devices Industry 15Global Coatings for Medical Devices Industry 16Global Coatings for Medical Devices Industry 17Global Coatings for Medical Devices Industry 18Global Coatings for Medical Devices Industry 19Global Coatings for Medical Devices Industry 20Global Coatings for Medical Devices Industry 21Paradigm Announces Molecular Profiling Collaboration with TESARO, Inc. 2
... FLORHAM PARK, N.J., March 24, 2011 Managed Health Care ... on alternate site health care providers, announced the completion of ... results of which were released at the 2011 MHA Long ... Nevada. This study was first introduced in ...
... CHICAGO, March 24, 2011 When it comes to ... According to a January 2011 survey by the American ... avoid losing their natural teeth. One way to help ... treatment. During Root Canal Awareness Week, March 27 – ...
Cached Medicine Technology:Managed Health Care Associates, Inc. (MHA) Released Results of Fourth Annual Independent Long Term Care Member Study with Highlights of Specialty Pharmaceutical Product Utilization 2Dispelling Myths of Root Canals Through Education 2
(Date:8/21/2014)... Baltimore, MD 21218 (PRWEB) August 21, 2014 ... company dedicated to aging interventions and addressing ... proposes a new concept, OncoFinder, for signalome-wide ... for accurate and robust cross-platform analysis of ... , The original research, published in the ...
(Date:8/20/2014)... Illinois (PRWEB) August 21, 2014 On September ... The Walk MS organization connects people living with MS with ... two million dollars and are 85% of the way to ... Junction City, registration begins at 11:30 and the walk starts ... will be available to answer question about chiropractic care and ...
(Date:8/20/2014)... 21, 2014 PAINWeek, the National ... that Ethan Nadelmann, JD, PhD, will deliver the ... the founder and executive director of the Drug ... States promoting alternatives to the war on drugs. ... both domestically and internationally, he has played a ...
(Date:8/20/2014)... August 21, 2014 Top10BestSEOHosting.com is ... reviews about hosting products. It is headed by ... experience. The site offers research-based information and factual ... suppliers in the current market. , Recently, ... announced that GoDaddy and Bluehost are ...
(Date:8/20/2014)... A new trend in the insurance ... before issuing an approximate quote for insurance coverage, according ... helping the public to obtain life insurance quotes without ... http://quotespros.com/life-insurance.html . , The coverage industry has changed ... appeared in many U.S. states. Some consumers are now ...
Breaking Medicine News(10 mins):Health News:OncoFinder, a new algorithm for minimizing errors in high-throughput transcriptome analysis 2Health News:Dr. Kelch of AlignLife North Peoria Supports Peoria Annual Walk MS 2Health News:PAINWeek Welcomes Ethan Nadelmann, JD, PhD, as Keynote Speaker at 2014 Conference 2Health News:New Reviews For Linux Web Hosting Suppliers Announced By Top10BestSEOHosting.com 2Health News:Life Insurance Quotes Without Medical Exams Now Displayed to Adults at Insurance Website 2
... Chief Science Officer Geri Dawson, Ph.D. and Assistant VP, Head of ... Hour: The Doctors Are In," a monthly live web chat with ... from 3:00 - 4:00 pm Eastern / 12:00 noon - 1:00 ... time of the web chat, viewers simply log in via the ...
... Salamon HealthDay Reporter , WEDNESDAY, Dec. 7 ... developing breast cancer by avoiding unnecessary medical radiation, forgoing ... don,t need to worry about using hair dyes or ... the body of research on environmental factors that may ...
... California,s low-income seniors with disabilities are struggling to remain in ... and may be slashed even further, according to a new ... with support from The SCAN Foundation. Should ... to In-Home Supportive Services (IHSS) on Dec. 15, as proposed ...
... NY)An antimalarial agent developed by researchers at Albert ... effective at clearing infections caused by the malaria parasite ... parasites to death. The novel research, carried out on ... to develop more potent therapies against one of the ...
... the main cause of complications and death from cancer. For ... development of these metastases themselves, instead of focusing on the ... a team from the Swiss Center for Experimental Cancer Research ... plays a major role in metastasis development, and showed that ...
... Fla. -- The use of two drugs never tried in ... 70 percent destruction of cancer cells already resistant to commonly ... Florida . Their report, published online in Gynecologic ... might offer a much needed treatment option for women with ...
Cached Medicine News:Health News:New Autism Speaks 'Office Hour: The Doctors Are In' monthly live web chat 2Health News:Expert Panel Pinpoints Environmental Culprits in Breast Cancer 2Health News:Expert Panel Pinpoints Environmental Culprits in Breast Cancer 3Health News:Expert Panel Pinpoints Environmental Culprits in Breast Cancer 4Health News:Older Californians with disabilities struggle to remain at home as public programs lose funding 2Health News:Older Californians with disabilities struggle to remain at home as public programs lose funding 3Health News:Older Californians with disabilities struggle to remain at home as public programs lose funding 4Health News:Novel drug wipes out deadliest malaria parasite through starvation 2Health News:Novel drug wipes out deadliest malaria parasite through starvation 3Health News:Nipping metastases in the bud 2Health News:Mayo Clinic researchers find drug duo kills chemotherapy-resistant ovarian cancer cells 2
Avitene Microfibrillar Collagen Hemostat (MCH) is used in surgical procedures as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical...
... Prodisc design is based upon the ... natural spinal motion segment unit. Kinematics ... integrates the biomechanical and anatomical aspects ... concept: Three implant components utilizing proven ...
3D Cranial is the most widely used surgical navigation software. Navigate with confidence and ease with displayed Zone of Accuracy and several fully automated features. 3D Cranial offers seamless int...
Designed for use during surgical procedures under fluoroscopy. A very practical unit, the frames superior design eliminates problems associated with imaging....
Medicine Products: